Morphological Changes in the Pituitary Gland of Dogs Chronically Exposed to Exogenous Growth Hormone

Abstract

Growth hormone (GH) synthesis and release from the pituitary is regulated by hypothalamic releasing hormone, insulin-like growth factor-1 (IGF-1), and somatostatin. However, the potential effects of pharmacological doses of exogenous GH on the pituitary are not well studied. To determine the potential chronic effects of exogenous GH on pituitary morphology in dogs, porcine GH (pGH) was administered subcutaneously to 3 groups of dogs (4 animals/sex/group) at doses of 0.025, 0.1, and 1.0 IU/kg/day for 14 wk. A group (4/sex) of dogs served as the vehicle control. The pituitaries from all dogs were weighed and fixed in appropriate fixatives for light and electron microscopic examination; in addition, cells of the pars distalis were quantitated by a point counting method following immunostaining to identify cells containing GH, prolactin (PRL), and adrenocorticotrophic (ACTH) hormones. Administration of pGH resulted in a statistically significant (p ≤ 0.05) increased pituitary weight through the high dose. By light microscopy (LM), hypertrophy of pars distalis cells was evident in mid- and high-dose female dogs. The pituitaries of dogs given the lowest dose (0.025 IU/kg/day) of pGH were not remarkable based on weight and LM findings. In addition, transmission electron microscopic (TEM) examination of the pituitary gland of high-dose dogs demonstrated, in both sexes, pituitary cells with variably dilated rough endoplasmic reticulum and decreased numbers of secretory granules; some of these cells reacted positively to GH immunostaining. Quantitative analysis of the pituitary gland of high-dose males and females showed an increase in the absolute volume of all cell populations studied: GH-, PRL-, and ACTH-positive cells. Based on the LM and TEM findings, the increased volume of the cell populations studied is likely related to cellular hypertrophy. The expected elevation in serum GH levels following repeated administration of pGH and an associated elevation in serum IGF-1 levels resulted in morphologic changes in the pituitary gland of dogs given high doses (≥0.1 IU/kg/day) of pGH; these observations differed from the reported findings in pituitaries of transgenic mice secreting large quantities of bovine GH.

Keywords

Somatotrophs lactotrophs adrenocorticotrophs transmission electron microscopy quantitative analysis

References

1. Andres CJ , Green ML , Clapper JA , Cline TR , Diekman MA , and Thomford PJ (1993). Influence of porcine somatotropin on endocrine and histological variables in gilts. J. Anim. Sci. 71: 1552–1560.

2. Ascacio-Martinez JA and Barrera-Saldana HA (1994). A dog growth hormone cDNA codes for a mature protein identical to pig growth hormone. Gene 143: 277–280.

3. Concannon P , Altszuler N , Hampshire J , Butler WR , and Hansel W (1980). Growth hormone, prolactin, and Cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Endocrinology 106(4): 1173–1177.

4. Eigenmann JE (1985). Growth hormone and insulin-like factor in the dog: Clinical and experimental investigations. Domest. Anim. Endocrinol. 2(1): 1–16.

5. Ghadially FN (1988). Endoplasmic reticulum. In: Ultrastructural Pathology of the Cell and Matrix, FN Ghadially (ed). Butterworths, London, Boston, Singapore, Sydney, Toronto and Wellington, pp. 428–435.

6. Harris AG (1996). Physiology of growth hormone. In: Acromegaly and Its Management, AF Daly (ed). Lippincott, Raven Publishers, Philadelphia, pp. 9–16.

7. Hartman ML , Veldhuis JD , and Thorner MO (1993). Normal control of growth hormone secretion. Horm. Res. 40: 37–47.

8. Inoue K and Sakai T (1991). Conversion of growth hormone-secreting cells into prolactin-secreting cells and its promotion by insulin and insulin-like growth factor-1 in vitro. Exp. Cell Res. 195: 53–58.

9. Laron I (1995). Growth hormone secretagogues: Clinical experience and therapeutic potential. Drugs 50(4): 595–601.

10.

10. Prahalada S , Stabinski LG , Chen HY , Morrissey RE , De Burlet G , Holder D , Patrick DH , Peter CP , and van Zwieten MJ (1998). Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs. Tox. Pathol. 26: 185–200.

11.

11. Schmidt P , Hafner A , Schams D , Weis S , Dahme E , and Schmahl W (1996). Depression of the somatotropic cells in the bovine pituitary gland due to application of recombinant bovine somatotropin–An immunohistochemical and morphometric study. Zentralbl. veterinaermed. A 43: 233–241.

12.

12. Selman PJ , Mol JA , Rutteman GR , van Garderen E , and Rijnberk A (1994). Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134(1): 287–292.

13.

13. Stefaneanu L , Kovacs K , Bartke A , Mayerhofer A , and Wagner TE (1993). Pituitary morphology of transgenic mice expressing bovine growth hormone. Lab. Invest. 68(5): 584–591.

14.

14. Stefaneanu L , Kovacs K , Horvath E , Losinski NE , Mayerhofer A , Wagner TE , and Bartke A (1990). An immunocytochemical and ultrastructural study of adenohypophyses of mice transgenic for “ human growth hormone. Endocrinology 126(1): 608–615.